#news #biotech Kapeller leaves Nimbus, ending CSO stint defined by virtual drug discovery successes

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Kapeller leaves Nimbus, ending CSO stint defined by virtual drug discovery successes .Rosana Kapeller, M.D., Ph.D., has left Nimbus Therapeutics after eight years in the CSO post. Kapeller departs having helped put virtual drug discovery on the map and land deals with Celgene, Genentech and Gilead.

from FierceBiotech: Biotech http://ift.tt/2p1UYWc